Very Small Embryonic-Like Stem Cells, Endothelial Progenitor Cells, and Different Monocyte Subsets Are Effectively Mobilized in Acute Lymphoblastic Leukemia Patients after G-CSF Treatment

<div>Changes in (a) CD34+ progenitor cells (CD34+ cells), (b) very small embryonic-like stem cells (VSELs, lin-CD235a-CD45-CD133+), (c) hematopoietic stem cells (HSC, lin-CD235a-CD45+CD133+), and (d) endothelial progenitor cell (EPCs, CD34+CD133+CD309+ cells) numbers in ALL patients after successful chemotherapy before and after G-CSF treatment; Wilcoxon test was used.</div>

Stem Cells International

fig2

Figure 2

Figure 2: Very Small Embryonic-Like Stem Cells, Endothelial Progenitor Cells, and Different Monocyte Subsets Are Effectively Mobilized in Acute Lymphoblastic Leukemia Patients after G-CSF Treatment 

Figure 2 | Very Small Embryonic-Like Stem Cells, Endothelial Progenitor Cells, and Different Monocyte Subsets Are Effectively Mobilized in Acute Lymphoblastic Leukemia Patients after G-CSF Treatment 